Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis b and c in special population groups (migrants, intravenous drug users and prison inmates)

Piero L. Almasio, Sergio Babudieri, Giorgio Barbarini, Maurizia Brunetto, Dario Conte, Pietro Dentico, Giovanni B. Gaeta, Claudio Leonardi, Massimo Levrero, Francesco Mazzotta, Aldo Morrone, Lorenzo Nosotti, Daniele Prati, Maria Rapicetta, Evangelista Sagnelli, Gaetano Scotto, Giulio Starnini

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

The global spread of hepatitis B virus (HBV) and hepatitis C virus (HCV), their high chronicity rates and their progression to cirrhosis and hepatocellular carcinoma, are major public health problems. Research and intervention programmes for special population groups are needed in order to assess their infection risk and set up suitable prevention and control strategies.Aim of this paper is to give health care professionals information on HBV and HCV infections amongst migrants, drug users and prison inmates. The manuscript is an official Position Paper on behalf of the following Scientific Societies: Italian Association for the Study of the Liver (A.I.S.F.), Italian Society of Infectious and Tropical Diseases (S.I.M.I.T.), Italian Federation Department's Operators and Addiction Services (FederSerD), Italian Prison Medicine and Healthcare Society (S.I.M.S.Pe.).The considered population groups, having a high prevalence HBV and HCV infections, require specific interventions. In this context, the expression " special population" refers to specific vulnerable groups at risk of social exclusion, such as migrants, prison inmates, and intravenous drug users. When dealing with special population groups, social, environmental and clinical factors should be considered when selecting candidates for therapy as indicated by national and international guidelines.

Original languageEnglish
Pages (from-to)589-595
Number of pages7
JournalDigestive and Liver Disease
Volume43
Issue number8
DOIs
Publication statusPublished - Aug 2011

Fingerprint

Prisons
Chronic Hepatitis
Drug Users
Population Groups
Hepatitis B virus
Hepacivirus
Virus Diseases
Delivery of Health Care
Manuscripts
Communicable Diseases
Hepatocellular Carcinoma
Fibrosis
Therapeutics
Public Health
Medicine
Guidelines
Liver
Infection
Research
Population

Keywords

  • HBV
  • HCV
  • Intravenous drug users
  • Migrants
  • Prison inmates

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis b and c in special population groups (migrants, intravenous drug users and prison inmates). / Almasio, Piero L.; Babudieri, Sergio; Barbarini, Giorgio; Brunetto, Maurizia; Conte, Dario; Dentico, Pietro; Gaeta, Giovanni B.; Leonardi, Claudio; Levrero, Massimo; Mazzotta, Francesco; Morrone, Aldo; Nosotti, Lorenzo; Prati, Daniele; Rapicetta, Maria; Sagnelli, Evangelista; Scotto, Gaetano; Starnini, Giulio.

In: Digestive and Liver Disease, Vol. 43, No. 8, 08.2011, p. 589-595.

Research output: Contribution to journalArticle

Almasio, PL, Babudieri, S, Barbarini, G, Brunetto, M, Conte, D, Dentico, P, Gaeta, GB, Leonardi, C, Levrero, M, Mazzotta, F, Morrone, A, Nosotti, L, Prati, D, Rapicetta, M, Sagnelli, E, Scotto, G & Starnini, G 2011, 'Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis b and c in special population groups (migrants, intravenous drug users and prison inmates)', Digestive and Liver Disease, vol. 43, no. 8, pp. 589-595. https://doi.org/10.1016/j.dld.2010.12.004
Almasio, Piero L. ; Babudieri, Sergio ; Barbarini, Giorgio ; Brunetto, Maurizia ; Conte, Dario ; Dentico, Pietro ; Gaeta, Giovanni B. ; Leonardi, Claudio ; Levrero, Massimo ; Mazzotta, Francesco ; Morrone, Aldo ; Nosotti, Lorenzo ; Prati, Daniele ; Rapicetta, Maria ; Sagnelli, Evangelista ; Scotto, Gaetano ; Starnini, Giulio. / Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis b and c in special population groups (migrants, intravenous drug users and prison inmates). In: Digestive and Liver Disease. 2011 ; Vol. 43, No. 8. pp. 589-595.
@article{19d0597ddf4f4b14bf4068944aacbf28,
title = "Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis b and c in special population groups (migrants, intravenous drug users and prison inmates)",
abstract = "The global spread of hepatitis B virus (HBV) and hepatitis C virus (HCV), their high chronicity rates and their progression to cirrhosis and hepatocellular carcinoma, are major public health problems. Research and intervention programmes for special population groups are needed in order to assess their infection risk and set up suitable prevention and control strategies.Aim of this paper is to give health care professionals information on HBV and HCV infections amongst migrants, drug users and prison inmates. The manuscript is an official Position Paper on behalf of the following Scientific Societies: Italian Association for the Study of the Liver (A.I.S.F.), Italian Society of Infectious and Tropical Diseases (S.I.M.I.T.), Italian Federation Department's Operators and Addiction Services (FederSerD), Italian Prison Medicine and Healthcare Society (S.I.M.S.Pe.).The considered population groups, having a high prevalence HBV and HCV infections, require specific interventions. In this context, the expression {"} special population{"} refers to specific vulnerable groups at risk of social exclusion, such as migrants, prison inmates, and intravenous drug users. When dealing with special population groups, social, environmental and clinical factors should be considered when selecting candidates for therapy as indicated by national and international guidelines.",
keywords = "HBV, HCV, Intravenous drug users, Migrants, Prison inmates",
author = "Almasio, {Piero L.} and Sergio Babudieri and Giorgio Barbarini and Maurizia Brunetto and Dario Conte and Pietro Dentico and Gaeta, {Giovanni B.} and Claudio Leonardi and Massimo Levrero and Francesco Mazzotta and Aldo Morrone and Lorenzo Nosotti and Daniele Prati and Maria Rapicetta and Evangelista Sagnelli and Gaetano Scotto and Giulio Starnini",
year = "2011",
month = "8",
doi = "10.1016/j.dld.2010.12.004",
language = "English",
volume = "43",
pages = "589--595",
journal = "Digestive and Liver Disease",
issn = "1590-8658",
publisher = "Elsevier B.V.",
number = "8",

}

TY - JOUR

T1 - Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis b and c in special population groups (migrants, intravenous drug users and prison inmates)

AU - Almasio, Piero L.

AU - Babudieri, Sergio

AU - Barbarini, Giorgio

AU - Brunetto, Maurizia

AU - Conte, Dario

AU - Dentico, Pietro

AU - Gaeta, Giovanni B.

AU - Leonardi, Claudio

AU - Levrero, Massimo

AU - Mazzotta, Francesco

AU - Morrone, Aldo

AU - Nosotti, Lorenzo

AU - Prati, Daniele

AU - Rapicetta, Maria

AU - Sagnelli, Evangelista

AU - Scotto, Gaetano

AU - Starnini, Giulio

PY - 2011/8

Y1 - 2011/8

N2 - The global spread of hepatitis B virus (HBV) and hepatitis C virus (HCV), their high chronicity rates and their progression to cirrhosis and hepatocellular carcinoma, are major public health problems. Research and intervention programmes for special population groups are needed in order to assess their infection risk and set up suitable prevention and control strategies.Aim of this paper is to give health care professionals information on HBV and HCV infections amongst migrants, drug users and prison inmates. The manuscript is an official Position Paper on behalf of the following Scientific Societies: Italian Association for the Study of the Liver (A.I.S.F.), Italian Society of Infectious and Tropical Diseases (S.I.M.I.T.), Italian Federation Department's Operators and Addiction Services (FederSerD), Italian Prison Medicine and Healthcare Society (S.I.M.S.Pe.).The considered population groups, having a high prevalence HBV and HCV infections, require specific interventions. In this context, the expression " special population" refers to specific vulnerable groups at risk of social exclusion, such as migrants, prison inmates, and intravenous drug users. When dealing with special population groups, social, environmental and clinical factors should be considered when selecting candidates for therapy as indicated by national and international guidelines.

AB - The global spread of hepatitis B virus (HBV) and hepatitis C virus (HCV), their high chronicity rates and their progression to cirrhosis and hepatocellular carcinoma, are major public health problems. Research and intervention programmes for special population groups are needed in order to assess their infection risk and set up suitable prevention and control strategies.Aim of this paper is to give health care professionals information on HBV and HCV infections amongst migrants, drug users and prison inmates. The manuscript is an official Position Paper on behalf of the following Scientific Societies: Italian Association for the Study of the Liver (A.I.S.F.), Italian Society of Infectious and Tropical Diseases (S.I.M.I.T.), Italian Federation Department's Operators and Addiction Services (FederSerD), Italian Prison Medicine and Healthcare Society (S.I.M.S.Pe.).The considered population groups, having a high prevalence HBV and HCV infections, require specific interventions. In this context, the expression " special population" refers to specific vulnerable groups at risk of social exclusion, such as migrants, prison inmates, and intravenous drug users. When dealing with special population groups, social, environmental and clinical factors should be considered when selecting candidates for therapy as indicated by national and international guidelines.

KW - HBV

KW - HCV

KW - Intravenous drug users

KW - Migrants

KW - Prison inmates

UR - http://www.scopus.com/inward/record.url?scp=79960369225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960369225&partnerID=8YFLogxK

U2 - 10.1016/j.dld.2010.12.004

DO - 10.1016/j.dld.2010.12.004

M3 - Article

VL - 43

SP - 589

EP - 595

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

SN - 1590-8658

IS - 8

ER -